產(chǎn)品展示
BOC-D-天冬氨酸62396-48-9公司專業(yè)銷售生化試劑,氨基酸類,酶類,蛋白質(zhì)類,植物激素及核酸類,碳水化合物類,色素類,緩沖劑類,培養(yǎng)基類,涉及到分析科學(xué),生命科學(xué),化學(xué),材料科學(xué)。了解更多產(chǎn)品!
BOC-D-天冬氨酸62396-48-9BOC-D-天冬氨酸/N-叔丁氧羰基-D-天冬氨酸/BOC-D-天/Boc-D-Asp-OH BR,98% 5克 ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌, 3726-67-5 RT
產(chǎn)品名稱 | |
英文名稱 | Boc-D-Asp-OH |
規(guī)格 | 可接受大包訂制 |
中文名稱:
其他中文名稱: N-叔丁氧羰基-D-天冬氨酸;BOC-D-天
英文名稱: Boc-D-Asp-OH
其他英文名稱: Boc-D-aspartic acid
產(chǎn)品規(guī)格: BR,98%
包裝:5克/25克/00克
:62396-48-9
C9H5NO6=233.22
級(jí)別:BR
含量:≥98.0%
比旋光度:+3.0~+7.0o(C=, methanol)
性狀:結(jié)晶粉末。
用途:生化研究。
保存:RT
我司產(chǎn)品品種達(dá)數(shù)萬(wàn)種,種類有高純度的生化試劑、分析試劑、化工中間體、催化劑、溶劑等各類化工產(chǎn)品。
質(zhì)量標(biāo)準(zhǔn):符合、企業(yè)標(biāo)準(zhǔn)及相關(guān)標(biāo)準(zhǔn)。
檢測(cè)方法:高效液相色譜法(HPLC≥98%)。
用途:用于蛋白質(zhì)及多肽等的合成,廣泛應(yīng)用于醫(yī)藥、生物化學(xué)、食品、化妝品等多種產(chǎn)品合成中。
運(yùn)輸:本品為生化試劑,不能與有毒、有害物品混運(yùn),可按一般化學(xué)品運(yùn)輸。
貯存:防止日曬、雨淋,應(yīng)貯存在干燥清潔避光的環(huán)境中,嚴(yán)禁與有毒物質(zhì)混放,以免污染。
是我司的優(yōu)勢(shì)產(chǎn)品,在行業(yè)中獲得許多客戶的贊譽(yù)。平易的價(jià)格,讓您補(bǔ)足實(shí)驗(yàn)“糧響”。我司專業(yè)供應(yīng)科研實(shí)驗(yàn)試劑,保質(zhì)保量。嚴(yán)格操作,技術(shù)成熟??蒲胁┐缶?,學(xué)科之間相互滲透,我們以滿足客戶需求為己任,力求全面服務(wù)于新老客戶。
檢測(cè)試劑盒 Biotin ELISA Kit
三聚氰銨ELISA快速檢測(cè)試劑盒 Melamine ELISA Kit
鳥類催乳素(PRL/LTH)ELISA Kit Avian Prolactin/Luteotropic Hormone,PRL/LTH ELISA Kit
鳥H5N IgG抗體ELSIA Kit Bird influenza A virus subtype H5N IgG antibody ELISA Kit
獼猴骨特異性堿性磷酸酶B(ALP-B)ELISA Kit Rhesus macaque bone-specific alkphase B,ALP-B ELISA Kit
家蠶卵黃蛋白(LT)ELISA Kit Bombyx mori Livetin,LT ELISA Kit
鯽魚卵黃蛋白原(VTG)ELISA Kit Crucian Vilogenin,VTG ELISA Kit
核黃素轉(zhuǎn)運(yùn)因子3(RFT3)ELISA Kit Human riboflavin transporter 3,RFT3 ELISA Kit
核黃素轉(zhuǎn)運(yùn)因子2(RFT2)ELISA Kit Human riboflavin transporter 2,RFT2 ELISA Kit
核黃素轉(zhuǎn)運(yùn)因子(RFT)ELISA Kit Human riboflavin transporter ,RFT ELISA Kit
核苷二磷酸激酶A(NDPK-A)ELISA Kit Nucleoside diphosphokinase A,NDPK-A ELISA kit
蝶蛹金小蜂卵黃蛋白原(Vtg)ELISA Kit Nasoniavitripennis vilogenin,Vtg ELISA Kit
大腸桿菌宿主殘留蛋白(E.coli P)ELISA Kit Escherichia coli protein,E.coli P ELISA kitRCS-4 M metabolite ( mg) 5-(3-(4-hydroxybenzoyl)-H-indol--yl)pentan-2-one; RCS-4 N-(4-oxo-pentyl)phenol metabolite; RCS-4 M metabolite
RCS-4 M metabolite (0 mg) 5-(3-(4-hydroxybenzoyl)-H-indol--yl)pentan-2-one; RCS-4 N-(4-oxo-pentyl)phenol metabolite; RCS-4 M metabolite
RCS-4 M metabolite (5 mg) 5-(3-(4-hydroxybenzoyl)-H-indol--yl)pentan-2-one; RCS-4 N-(4-oxo-pentyl)phenol metabolite; RCS-4 M metabolite
Sumanirole Maleate ( mg) 5R,6-dihydro-5-(methylamino)-2Z-butenedioate-4H-imidazo[4,5,-ij]quinolin-2(H)-one; PNU 95666; Sumanirole Maleate
Sumanirole Maleate (0 mg) 5R,6-dihydro-5-(methylamino)-2Z-butenedioate-4H-imidazo[4,5,-ij]quinolin-2(H)-one; PNU 95666; Sumanirole Maleate
Sumanirole Maleate (5 mg) 5R,6-dihydro-5-(methylamino)-2Z-butenedioate-4H-imidazo[4,5,-ij]quinolin-2(H)-one; PNU 95666; Sumanirole Maleate
Biphenylindanone A (0 mg) 3’-[[(2-cyclopentyl-2,3-dihydro-6,7-dimethyl--oxo-H-inden-5-yl)oxy]methyl]-[,’-biphenyl]-4-carboxylic acid; BINA|MRLSD 23Biphenylindanone A
Biphenylindanone A (25 mg) 3’-[[(2-cyclopentyl-2,3-dihydro-6,7-dimethyl--oxo-H-inden-5-yl)oxy]methyl]-[,’-biphenyl]-4-carboxylic acid; BINA|MRLSD 23Biphenylindanone A
Biphenylindanone A (5 mg) 3’-[[(2-cyclopentyl-2,3-dihydro-6,7-dimethyl--oxo-H-inden-5-yl)oxy]methyl]-[,’-biphenyl]-4-carboxylic acid; BINA|MRLSD 23Biphenylindanone A
Cinnabarinic Acid (0 mg) 2-amino-3-oxo-3H-phenoxazine-,9-dicarboxylic acid; Cinnabarinic Acid
Cinnabarinic Acid (50 mg) 2-amino-3-oxo-3H-phenoxazine-,9-dicarboxylic acid; Cinnabarinic Acid
NPS 2390 (0 mg) N-tricyclo[3。3。。3,7]dec--yl-2-quinoxalinecarboxamide; NPS 2390
NPS 2390 (25 mg) N-tricyclo[3。3。。3,7]dec--yl-2-quinoxalinecarboxamide; NPS 2390
NPS 2390 (5 mg) N-tricyclo[3。3。。3,7]dec--yl-2-quinoxalinecarboxamide; NPS 2390
Ro 0-628 ( mg) N-(2,2-diphenylacetyl)-ethyl ester-carbamic acid; Ro 0-628
Ro 0-628 (0 mg) N-(2,2-diphenylacetyl)-ethyl ester-carbamic acid; Ro 0-628
Ro 0-628 (5 mg) N-(2,2-diphenylacetyl)-ethyl ester-carbamic acid; Ro 0-628
Ro 67-4853 ( mg) N-(9H-xanthen-9-ylcarbonyl)-butyl ester-carbamic acid; Ro 67-4853
Ro 67-4853 (0 mg) N-(9H-xanthen-9-ylcarbonyl)-butyl ester-carbamic acid; Ro 67-4853
Ro 67-4853 (5 mg) N-(9H-xanthen-9-ylcarbonyl)-butyl ester-carbamic acid; Ro 67-4853
VU0360223 ( mg) 3-fluoro-5-(2-methyl-5-benzothiazolyl)-benzonitrile; CAY065; VU0360223
VU0360223 (0 mg) 3-fluoro-5-(2-methyl-5-benzothiazolyl)-benzonitrile; CAY065; VU0360223
VU0360223 (5 mg) 3-fluoro-5-(2-methyl-5-benzothiazolyl)-benzonitrile; CAY065; VU0360223
VU0360223 (50 mg) 3-fluoro-5-(2-methyl-5-benzothiazolyl)-benzonitrile; CAY065; VU0360223
JNJ-5207852 (0 mg) -[3-[4-(-piperidinylmethyl)phenoxy]propyl]-piperidine; JNJ-5207852
JNJ-5207852 (5 mg) -[3-[4-(-piperidinylmethyl)phenoxy]propyl]-piperidine; JNJ-5207852
JNJ-5207852 (50 mg) -[3-[4-(-piperidinylmethyl)phenoxy]propyl]-piperidine; JNJ-5207852
Olopatadine (hydrochloride) (0 mg) Z-[3-(dimethylamino)propylidene]-6,-dihydro-dibenz[b,e]oxepin-2-acetic acid, monohydrochloride; ALO 4943A|Allerock|KW 4679|Olopine|Patanase; Olopatadine (hydrochloride)
Olopatadine (hydrochloride) (00 mg) Z-[3-(dimethylamino)propylidene]-6,-dihydro-dibenz[b,e]oxepin-2-acetic acid, monohydrochloride; ALO 4943A|Allerock|KW 4679|Olopine|Patanase; Olopatadine (hydrochloride)
Olopatadine (hydrochloride) (25 mg) Z-[3-(dimethylamino)propylidene]-6,-dihydro-dibenz[b,e]oxepin-2-acetic acid, monohydrochloride; ALO 4943A|Allerock|KW 4679|Olopine|Patanase; Olopatadine (hydrochloride)